AIM ImmunoTech Inc. (AIM)
Largest Insider Buys in Sector
AIM Stock Price History Chart
AIM Stock Performance
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat genital warts, a sexually transmitted disease. It has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Insider Activity of AIM ImmunoTech Inc.
Over the last 12 months, insiders at AIM ImmunoTech Inc. have bought $206,361 and sold $884 worth of AIM ImmunoTech Inc. stock.
On average, over the past 5 years, insiders at AIM ImmunoTech Inc. have bought $102,373 and sold $884 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Equels Thomas K (CEO & President) — $118,187. APPELROUTH STEWART (director) — $48,173. Rodino Peter W III (COO, Secretary, Gen. Counsel) — $25,000.
The last purchase of 22,727 shares for transaction amount of $4,682 was made by Equels Thomas K (CEO & President) on 2024‑12‑18.
List of Insider Buy and Sell Transactions, AIM ImmunoTech Inc.
| 2024-12-19 | Sale | director | 4,580 0.0071% | $0.19 | $884 | 0.00% | ||
| 2024-12-18 | CEO & President | 22,727 0.035% | $0.21 | $4,682 | -5.15% | |||
| 2024-12-02 | director | 11,112 0.0168% | $0.21 | $2,356 | -3.23% | |||
| 2024-11-20 | CEO & President | 145,110 0.2237% | $0.19 | $27,915 | +5.55% | |||
| 2024-11-20 | CEO & President | 85,000 0.1355% | $0.20 | $16,915 | +5.55% | |||
| 2024-11-20 | CEO & President | 60,110 0.0881% | $0.18 | $11,000 | +5.55% | |||
| 2024-11-20 | director | 81,953 0.1267% | $0.19 | $15,817 | +5.55% | |||
| 2024-09-16 | CEO & President | 5,000 0.0089% | $0.30 | $1,515 | -18.52% | |||
| 2024-09-13 | CEO & President | 20,000 0.0363% | $0.31 | $6,160 | -18.49% | |||
| 2024-05-06 | CEO & President | 61,729 0.117% | $0.41 | $25,000 | -28.98% | |||
| 2024-05-06 | COO, Secretary, Gen. Counsel | 30,865 0.0585% | $0.41 | $12,500 | -28.98% | |||
| 2024-03-21 | director | 38,462 0.0806% | $0.39 | $15,000 | -8.79% | |||
| 2024-03-15 | CEO & President | 75,758 0.1551% | $0.33 | $25,000 | +6.29% | |||
| 2024-03-15 | director | 90,910 0.1861% | $0.33 | $30,000 | +6.29% | |||
| 2024-03-15 | COO, Secretary, Gen. Counsel | 37,879 0.0776% | $0.33 | $12,500 | +6.29% | |||
| 2023-11-27 | CEO & President | 33,861 0.0699% | $0.44 | $15,000 | -6.98% | |||
| 2023-09-29 | CEO & President | 22,676 0.0452% | $0.44 | $10,000 | -6.80% | |||
| 2023-08-25 | CEO & President | 8,222 0.0169% | $0.67 | $5,501 | -34.28% | |||
| 2023-08-24 | CEO & President | 14,993 0.0308% | $0.67 | $10,000 | -35.27% | |||
| 2023-07-17 | CEO & President | 16,950 0.0334% | $0.59 | $10,001 | -27.42% |
Insider Historical Profitability
| Equels Thomas K | CEO & President | 1680695 2.6352% | $0.22 | 44 | 0 | <0.0001% |
| APPELROUTH STEWART | director | 355509 0.5574% | $0.22 | 10 | 0 | <0.0001% |
| Rodino Peter W III | COO, Secretary, Gen. Counsel | 212583 0.3333% | $0.22 | 5 | 0 | <0.0001% |
| MITCHELL WILLIAM M | director | 118549 0.1859% | $0.22 | 2 | 1 | <0.0001% |
| BRYAN NANCY | director | 38462 0.0603% | $0.22 | 1 | 0 | |
| CARTER WILLIAM A | CEO | 1225585 1.9216% | $0.22 | 12 | 3 | |
| Bernhardt Charles Thomas III | Chief Financial Officer | 265214 0.4158% | $0.22 | 2 | 1 | |
| Lander Russel J | VP of Process/QualityAssurance | 207983 0.3261% | $0.22 | 4 | 0 | |
| SPENCE STEVEN D | director | 201742 0.3163% | $0.22 | 9 | 0 | |
| PIANI RICHARD | director | 161071 0.2525% | $0.22 | 2 | 0 | |
| ETHERIDGE RANSOM | director | 122560 0.1922% | $0.22 | 1 | 0 | |
| PASCALE ADAM | CFO | 59648 0.0935% | $0.22 | 3 | 0 | <0.0001% |
| SPRINGATE WAYNE S | Sr. VP of Operations | 8672 0.0136% | $0.22 | 6 | 1 | <0.0001% |
| PETERSON ROBERT E | Chief Financial Officer | 8000 0.0125% | $0.22 | 1 | 0 | |
| STRAYER DAVID R | Chief Science/Medical Officer | 5420 0.0085% | $0.22 | 10 | 2 | <0.0001% |
| Bonelli Anthony | President & COO | 2500 0.0039% | $0.22 | 1 | 0 | |
| Dickey Robert IV | Senior Vice President | 2500 0.0039% | $0.22 | 1 | 0 |
Institutional Investor Ownership
| The Vanguard Group | $936,680.00 | 3.48 | 1.99M | 0% | +$0 | <0.0001 | |
| BlackRock | $328,915.00 | 1.22 | 698,333 | -1.34% | -$4,461.78 | <0.0001 | |
| Geode Capital Management | $165,689.00 | 0.62 | 351,657 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $104,000.00 | 0.39 | 220,808 | +9.31% | +$8,854.75 | <0.0001 | |
| State Street | $81,532.00 | 0.3 | 173,103 | 0% | +$0 | <0.0001 | |
| Verition Fund Management Llc | $80,541.00 | 0.3 | 171,000 | +5.56% | +$4,239.00 | <0.01 | |
| Bridgeway Capital Management | $51,292.00 | 0.19 | 108,900 | 0% | +$0 | <0.01 | |
| Northern Trust | $40,132.00 | 0.15 | 85,206 | -0.42% | -$169.56 | <0.0001 | |
| Morgan Stanley | $40,186.00 | 0.15 | 85,320 | +10.35% | +$3,768.97 | <0.0001 | |
| SeaCrest Investment Management, LLC | $16,515.00 | 0.06 | 35,063 | -5.4% | -$942.02 | <0.01 | |
| DRW Securities LLC | $11,304.00 | 0.04 | 24,000 | -4% | -$471.00 | <0.01 | |
| TWO SIGMA SECURITIES LLC | $10,089.00 | 0.04 | 21,420 | New | +$10,089.00 | <0.0001 | |
| CAPTRUST | $9,420.00 | 0.04 | 20,000 | 0% | +$0 | <0.0001 | |
| Forthright Wealth Management Llc | $9,420.00 | 0.04 | 20,000 | 0% | +$0 | <0.01 | |
| Tower Research Capital | $8,565.00 | 0.03 | 18,183 | -3.78% | -$336.33 | <0.0001 | |
| Susquehanna International Group | $7,927.00 | 0.03 | 16,830 | +10.72% | +$767.27 | <0.0001 | |
| Xtx Topco Ltd | $6,648.00 | 0.03 | 14,115 | New | +$6,648.00 | <0.0001 | |
| Community Bank, N.A. | $6,216.00 | 0.02 | 13,226 | 0% | +$0 | <0.01 | |
| Traynor Capital Management Inc | $5,547.00 | 0.02 | 11,777 | 0% | +$0 | <0.01 | |
| D B Root Company Llc | $5,676.00 | 0.02 | 12,050 | 0% | +$0 | <0.01 | |
| Hoey Investments Inc | $471.00 | <0.01 | 1,000 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $470.00 | <0.01 | 1,000 | -36.99% | -$275.89 | <0.0001 | |
| Fidelity Investments | $245.00 | <0.01 | 521 | +10,320% | +$242.65 | <0.0001 | |
| Wells Fargo | $353.00 | <0.01 | 751 | +0.81% | +$2.82 | <0.0001 | |
| AdvisorNet Financial | $236.00 | <0.01 | 500 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $1.00 | <0.01 | 2 | 0% | +$0 | <0.0001 | |
| UBS | $10.00 | <0.01 | 21 | -99.84% | -$6,119.05 | <0.0001 | |
| Huntington National Bank | $27.00 | <0.01 | 57 | 0% | +$0 | <0.0001 | |
| Newedge Advisors Llc | $0 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| CWM LLC | $0 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 180 | +0.56% | +$0 | <0.0001 | |
| JPMorgan Chase | $51.00 | <0.01 | 110 | +26.44% | +$10.66 | <0.0001 | |
| Bank of America | $0 | <0.01 | 1 | -98.31% | -$0 | <0.0001 |